TERN-201 NASH clinical trial : Terns Pharmaceuticals said that an ongoing phase 1 trial of its semicarbazide-sensitive amine oxidase (SSAO) inhibitor TERN-201 in non-alcoholic steatohepatitis (NASH) has yielded positive results. According to the US biopharma company, the early-stage NASH clinical study showed that a single oral dose of TERN-201 delivered a sustained, near-complete suppression of […]
LABORIE acquisition of Clinical Innovations : LABORIE Medical Technologies has agreed to acquire Utah-based Clinical Innovations for $525 million from EQT Mid Market US fund and the EQT Mid Market Asia III fund (jointly EQT). Headquartered in Salt Lake City, Clinical Innovations provides medical devices for the labor and delivery (L&D) and neonatal intensive care […]
Solar acquisition news : US Solar Fund, a UK-based investment company, has signed an agreement to acquire the 128MW Milford Solar Project to be built in Utah from Longroad Energy Partners. The electricity generated from the Milford Solar Project, which is expected to be commissioned in the second half of 2020, will be sold completely […]